Drug Information Association Logo

Biography:

Dr. Mu has over 18 years of clinical research and development experience, having held medical and clinical leadership positions with several global pharmaceutical and biotech companies, including Roche, Abraxis Bioscience (now Celgene), Biogen Idec, Genentech, and Procter and Gamble. Dr. Mu's responsibilities have included early- to late-stage development of cytotoxic agents, small molecules, and monoclonal antibodies; management of clinical and regulatory organizations; creation and oversight of external collaborations and partnerships; interaction with regulatory authorities in the United States, Europe and Asia; and advancement of drug candidates to market and through their post-market development. Before joining WuXi, Dr. Mu was the Executive Vice President and Chief Medical Officer at Hutchison MediPharma, a company that in four years has successfully obtained five IND approvals and one Phase II/III CTA approval from the China Food and Drug Administration and advanced six compounds into various stages of clinical development. Dr. Mu received his medical degree from West China University of Medical Sciences and a Ph.D. in epidemiology from the University of California at Berkeley, under the mentorship of Dr. Mary-Claire King, a renowned cancer geneticist and the discoverer of the breast cancer BRCA gene. Earlier in his career, Dr. Mu was a Senior Fellow at the Schools of Medicine of the University of California in San Francisco and the University of Washington, where he conducted translational research on autoimmune diseases and breast cancer.